Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy

Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and... Acta Biomaterialia 71 (2018) 351–362 Contents lists available at ScienceDirect Acta Biomaterialia journal homepage: www.elsevier.com/locate/actabiomat Full length article Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy a,1 a,1 a a a a Zhiqi Xie , Wangwei Guo , Ningning Guo , Mingyi Huangfu , Huina Liu , Mengting Lin , b b a b a,⇑ a,⇑ WenHong Xu , Jiejian Chen , TianTian Wang , Qichun Wei , Min Han , Jianqing Gao College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, PR China Department of Radiation Oncology, Key Laboratory of Cancer Prevention and Intervention, The Second Affiliated Hospital, Zhejiang University, College of Medicine, Hangzhou 310058, PR China article i nfo abstract Article history: Although existing nanomedicines have focused on the tumor microenvironment with the goal of improv- Received 9 October 2017 ing the effectiveness of conventional chemotherapy, the penetration of a tumor’s core still represents a Received in revised form 23 February 2018 formidable barrier for existing drug delivery systems. Therefore, a novel multifunctional hypoxia- Accepted 6 March 2018 induced size-shrinkable nanoparticle has been designed to increase the penetration of drugs, nucleic Available online 13 March 2018 acids, or probes into tumors. This http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Acta Biomaterialia Elsevier

Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy

Loading next page...
 
/lp/elsevier/targeting-tumor-hypoxia-with-stimulus-responsive-nanocarriers-in-w53LO8t2N1
Publisher
Elsevier
Copyright
Copyright © 2018 Acta Materialia Inc.
ISSN
1742-7061
eISSN
1878-7568
D.O.I.
10.1016/j.actbio.2018.03.013
Publisher site
See Article on Publisher Site

Abstract

Acta Biomaterialia 71 (2018) 351–362 Contents lists available at ScienceDirect Acta Biomaterialia journal homepage: www.elsevier.com/locate/actabiomat Full length article Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy a,1 a,1 a a a a Zhiqi Xie , Wangwei Guo , Ningning Guo , Mingyi Huangfu , Huina Liu , Mengting Lin , b b a b a,⇑ a,⇑ WenHong Xu , Jiejian Chen , TianTian Wang , Qichun Wei , Min Han , Jianqing Gao College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, PR China Department of Radiation Oncology, Key Laboratory of Cancer Prevention and Intervention, The Second Affiliated Hospital, Zhejiang University, College of Medicine, Hangzhou 310058, PR China article i nfo abstract Article history: Although existing nanomedicines have focused on the tumor microenvironment with the goal of improv- Received 9 October 2017 ing the effectiveness of conventional chemotherapy, the penetration of a tumor’s core still represents a Received in revised form 23 February 2018 formidable barrier for existing drug delivery systems. Therefore, a novel multifunctional hypoxia- Accepted 6 March 2018 induced size-shrinkable nanoparticle has been designed to increase the penetration of drugs, nucleic Available online 13 March 2018 acids, or probes into tumors. This

Journal

Acta BiomaterialiaElsevier

Published: Apr 15, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off